Published in Immunology on April 01, 1994
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev (1995) 2.06
Lentivirus-induced immune dysregulation. Vet Immunol Immunopathol (2008) 0.93
Clinical aspects of feline retroviruses: a review. Viruses (2012) 0.91
Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection. J Virol (2003) 0.89
Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study. Immunology (1995) 0.82
The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression. J Virol (1998) 0.81
Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies. PLoS One (2013) 0.78
Circulating immune complexes and analysis of renal immune deposits in feline immunodeficiency virus-infected cats. Clin Exp Immunol (1995) 0.77
Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection. J Immunol Methods (2013) 0.75
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (1993) 11.15
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med (1983) 10.09
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol (1990) 2.40
Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol (1983) 1.86
Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol (1991) 1.83
HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol (1989) 1.66
Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature (1993) 1.56
Feline immunodeficiency virus: a brief review. Br Vet J (1992) 1.42
Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med (1988) 1.23
Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Res Hum Retroviruses (1990) 1.19
Serological responses of cats to feline immunodeficiency virus. AIDS (1990) 1.14
Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. AIDS (1991) 1.08
Clinical and pathological findings in feline immunodeficiency virus experimental infection. Vet Immunol Immunopathol (1992) 0.99
Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968-1988). J Acquir Immune Defic Syndr (1990) 0.97
HIV induces IL-6 production by human B lymphocytes. Role of IL-4. J Immunol (1992) 0.96
Lymphosarcoma in experimentally induced feline immunodeficiency virus infection [corrected]. Vet Rec (1992) 0.92
Feline leukemia virus and feline immunodeficiency virus infections in a cat with lymphoma. J Am Vet Med Assoc (1989) 0.87
Decreased mitogen responsiveness and elevated tumor necrosis factor production in cats shortly after feline immunodeficiency virus infection. Vet Immunol Immunopathol (1992) 0.83
Immunocytochemical determination of antigen and epitope specificity of HIV-1-specific B cells in lymph-node biopsies from HIV-1-infected individuals. AIDS (1991) 0.82
Comparative analyses of multi-species sequences from targeted genomic regions. Nature (2003) 13.31
Human-mouse genome comparisons to locate regulatory sites. Nat Genet (2000) 8.08
Gibbs motif sampling: detection of bacterial outer membrane protein repeats. Protein Sci (1995) 5.96
Phylogenetic footprinting of transcription factor binding sites in proteobacterial genomes. Nucleic Acids Res (2001) 4.29
A test of the negative discriminative stimulus as a reinforcer of observing. J Exp Anal Behav (1972) 3.76
Natural selection of life history attributes: an analytical approach. Theor Popul Biol (1974) 3.50
Extracting protein alignment models from the sequence database. Nucleic Acids Res (1997) 3.17
An empirical energy function for threading protein sequence through the folding motif. Proteins (1993) 2.94
Estimated effect of breast self-examination and routine physician examinations on breast-cancer mortality. N Engl J Med (1978) 2.60
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond. Nucleic Acids Res (2001) 2.09
Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections. Vet Rec (2001) 2.08
Bayesian inference on biopolymer models. Bioinformatics (1999) 2.02
Horizontal transmission of leukemia virus and leukemia in the cat. J Natl Cancer Inst (1973) 2.00
Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J Exp Med (2000) 1.98
Functional classification of cNMP-binding proteins and nucleotide cyclases with implications for novel regulatory pathways in Mycobacterium tuberculosis. Genome Res (2000) 1.79
Extent and nature of contacts between protein molecules in crystal lattices and between subunits of protein oligomers. Proteins (1997) 1.79
The frequency of occurrence of feline leukaemia virus subgroups in cats. Int J Cancer (1978) 1.66
Determinants of the host range of feline leukaemia viruses. J Gen Virol (1973) 1.64
Quantitative analysis of ribosome binding sites in E.coli. Nucleic Acids Res (1994) 1.63
Biology of feline leukemia virus in the natural environment. Cancer Res (1976) 1.59
Algorithms for the optimal identification of segment neighborhoods. Bull Math Biol (1989) 1.51
The relation of polychlorinated biphenyls to birth weight and gestational age in the offspring of occupationally exposed mothers. Am J Epidemiol (1989) 1.50
Incubation periods for paediatric AIDS patients. Nature (1988) 1.47
Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J Lab Clin Med (1995) 1.46
Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions. J Immunol (1983) 1.44
Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec (1989) 1.43
Diagnostic sensitivity bias -- an epidemiologic explanation for an apparent brain tumor excess. J Occup Med (1981) 1.41
Vaccination against feline leukaemia virus. Vet Rec (1994) 1.39
Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol (2003) 1.36
Replication of cat leukemia virus in cell cultures. Nature (1968) 1.34
Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol (1992) 1.33
Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS (1991) 1.33
A bayesian statistical algorithm for RNA secondary structure prediction. Comput Chem (1999) 1.33
Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion. J Natl Cancer Inst (1971) 1.25
Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology (1991) 1.25
Isolation of the nucleic acid of feline leukemia virus. Virology (1971) 1.25
A study of naturally occurring feline coronavirus infections in kittens. Vet Rec (1992) 1.24
Bayesian adaptive sequence alignment algorithms. Bioinformatics (1998) 1.22
Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. J Immunol (1985) 1.22
Differential growth and transmission in cats of feline leukaemia viruses of subgroups A and B. Int J Cancer (1978) 1.21
Detection of likely transmembrane beta strand regions in sequences of mitochondrial pore proteins using the Gibbs sampler. J Bioenerg Biomembr (1996) 1.21
Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology (1993) 1.17
A monoclonal antibody which blocks infection with feline immunodeficiency virus identifies a possible non-CD4 receptor. J Virol (1993) 1.15
Serological responses of cats to feline immunodeficiency virus. AIDS (1990) 1.14
Selective effect of feline leukaemia virus on early erythroid precursors. Nature (1982) 1.12
Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol (1995) 1.11
The frequency of ion-pair substructures in proteins is quantitatively related to electrostatic potential: a statistical model for nonbonded interactions. Proteins (1991) 1.11
Polychlorinated biphenyls: influence on birthweight and gestation. Am J Public Health (1984) 1.11
Immunopathology of intestinal helminth infection. Parasite Immunol (2000) 1.11
Interaction between feline leukaemia virus subgroups in the pathogenesis of erythroid hypoplasia. Int J Cancer (1984) 1.10
Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology (1994) 1.09
Use of a reverse-transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by healthy cats. Vet Rec (2001) 1.09
Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. AIDS (1991) 1.08
Immunosuppressive proteins secreted by the gastrointestinal nematode parasite Heligmosomoides polygyrus. Int J Parasitol (1994) 1.06
Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates. J Gen Virol (1994) 1.06
Trihalomethanes in drinking water and human colorectal cancer. J Natl Cancer Inst (1984) 1.06
Viral oncogenesis: lessons from naturally occurring animal viruses. Cancer Surv (1987) 1.05
Vaccination against feline leukaemia virus using a cell membrane antigen system. Int J Cancer (1975) 1.04
Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol (1992) 1.03
Anemia associated with feline leukemia virus infection in cats. J Natl Cancer Inst (1975) 1.03
Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household. Int J Cancer (1977) 1.02
Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. J Virol (1993) 1.01
DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J Virol (1998) 1.01
Detection of transient and persistent feline leukaemia virus infections. Vet Rec (1982) 1.00
A comparison of DNA amplification, isolation and serology for the detection of Chlamydia psittaci infection in cats. Vet Rec (1998) 1.00
Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J Immunol (1996) 1.00
Preparing for mandatory continuing education--assessing interests. J Contin Educ Nurs (1993) 1.00
Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases. J Natl Cancer Inst (1975) 0.99
AIDS behind bars. Epidemiology of New York State prison inmate cases, 1980-1988. N Y State J Med (1990) 0.99
A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J Virol (1996) 0.99
Clinical and pathological findings in feline immunodeficiency virus experimental infection. Vet Immunol Immunopathol (1992) 0.99
Anatomy of a preferred target site for the bacterial insertion sequence IS903. J Mol Biol (2001) 0.99
Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus. Vet Rec (2000) 0.98
Polypeptides of feline leukemia virus: a glycosylated gag-related protein is released into culture fluids. Virology (1980) 0.98
Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Vet Pathol (1996) 0.98
The role of IL-4, IL-13 and IL-4Ralpha in the development of protective and pathological responses to Trichinella spiralis. Parasite Immunol (2007) 0.96
Tonsillectomy and childhood Hodgkin's disease. Lancet (1980) 0.95
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. J Virol (2000) 0.95
Feline viruses in wildcats from Scotland. J Wildl Dis (1999) 0.95
Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus. AIDS Res Hum Retroviruses (1995) 0.94
Suppression of virus burden by immunization with feline immunodeficiency virus Env protein. Vaccine (1996) 0.94
Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide. J Virol (1994) 0.93
The whys of patient education. Semin Oncol Nurs (1991) 0.93
Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. J Virol (2001) 0.93
Estimating serum polychlorinated biphenyl levels in highly exposed workers: an empirical model. J Toxicol Environ Health (1991) 0.92
Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain. Immunology (1995) 0.92
Antibodies in normal and leukemic cats to feline oncornavirus-associated cell membrane antigens. J Natl Cancer Inst (1973) 0.92
Coordinated Muc2 and Muc3 mucin gene expression in Trichinella spiralis infection in wild-type and cytokine-deficient mice. Dig Dis Sci (2001) 0.92
Lymphosarcoma in experimentally induced feline immunodeficiency virus infection [corrected]. Vet Rec (1992) 0.92
Feline leukaemia virus proviral DNA detected by polymerase chain reaction in antigenaemic but non-viraemic ('discordant') cats. Arch Virol (1997) 0.92
Growth of feline leukaemia virus in human cells. Nature (1969) 0.91
Value of alpha 1-acid glycoprotein in the diagnosis of feline infectious peritonitis. Vet Rec (1997) 0.91
An electron microscopic study of virus particles in spontaneous leukemia in the cat. J Natl Cancer Inst (1968) 0.91